HMR NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Heidmar Maritime Holdings Corp. Common Stock · Industrials · Marine Shipping

Open interactive chart View report data Download investor PDF
Latest close 1.15 USD
7.5% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 13.8% above the Trend Line and sits at 42.9% of its 52-week range. The latest completed week returned 7.5%, after a -5.7% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal; earnings are due in 11d.

Setup score 35 out of 100
Latest Close 1.15 USD 24 Jul 2026
1W Return 7.5% latest completed week
4W Return -5.7% short-term follow-through
12W Return 42.9% quarterly tape
Trend Breadth 15.4% 8 of 52 weeks active
Volume Ratio 0.3x vs 13-week average
What is working
  • The trend backdrop is active with a 8-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 40.93% based on similar historical setup states.
  • The share remains more than 20% below its 52-week high.
  • Recent volatility is running well above the one-year baseline.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 7.5% Latest completed week; four-week move -5.7%. Indicator stack 36/52 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 40.93% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 50/100 30 relevant articles in the latest sentiment read. Event risk 11d Next report is scheduled for 10 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 13.8% above the Trend Line and sits at 42.9% of its 52-week range. The latest completed week returned 7.5%, after a -5.7% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.3x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.6312-week average 0.31

12-week confirmation

Trend active8/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership2/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.63Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -5.7% over four weeks, 42.9% over 12 weeks, and -25.3% over one year. The current trend has remained active for 8 consecutive weeks.

Performance by holding period

1W7.5%
4W-5.7%
12W42.9%
26W8.5%
52W-25.3%
Active trend streak8 weeks
Active weeks in one year8
Trend breadth15.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.40Latest activity-pressure read.
Pressure change-66.6%Four-week change in activity pressure.
Leadership-6.06Latest relative-leadership reading.
RS change31.2%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 85% Model confidence 81%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength58/100Blend of value, momentum, and quality. Underlying universe rank 43; rank 1 is best.
Value53/100Relative valuation strength. Underlying universe rank 48; rank 1 is best.
Quality52/100Profitability and accounting quality. Underlying universe rank 49; rank 1 is best.
Momentum53/100Medium-term price momentum. Underlying universe rank 48; rank 1 is best.
Growth53/100Revenue and earnings growth. Underlying universe rank 48; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
0.8x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
16.2%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
75.8%
Gross profit retained from each unit of revenue.
Operating margin
-9.5%
Operating profit retained from revenue.
Free-cash-flow margin
17.6%
Free cash flow generated from revenue.
Return on invested capital
-15.9%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
11.8%
Cash dividends relative to market value.
Buyback yield
-0.4%
Net share repurchases relative to market value.
Shareholder yield
11.4%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-9.5x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 30 relevant articles.

3 positive · 26 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings11dNext report is scheduled for 10 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-32.7%Distance below the 52-week high.
13-week volatility18.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2614 weeks finished lower.
Best week+48.5%Week of 22 May.
Worst week-18.0%Week of 29 May.
Latest week+7.5%Week of 24 Jul.

Shape of recent returns

Strong gains7
Modest gains4
Flat weeks1
Modest losses6
Sharp losses8
Recent vol18.7%13-week weekly-return volatility.
Base vol12.0%52-week weekly-return volatility.
Up/down split19/29Count of positive and negative weeks in the 52-week window.
Average skew11.0% / -7.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape31/100

Trend, activity pressure, participation, and risk combine to a 31/100 tape read.

 Indicator analysis61/100

Latest 12-week confirmation: trend 8/12, activity pressure 12/12, relative leadership 2/12.

Activity pressure 0.63; No reversal markers Next-Week ExpectancyNegative 40.93%

Next-week expectancy is negative with a 40.93% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors53/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Tiny Titans rank 44; Buyback Yield rank 75; Small Cap Core rank 52 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 30 relevant articles.

Seanergy Maritime Holdings Corp. Revenue Breakdown – TRADEGATE:RHS Insiders50/100

No recent insider transaction evidence is stored.

 Earnings11d

Next report is scheduled for 10 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 20261.15 USD7.5%1.01 USD1.50 USD0.40-6.06316.1KOn
17 Jul 20261.07 USD0.0%1.00 USD1.50 USD0.59-14.94247.1KOn
10 Jul 20261.07 USD-10.8%1.00 USD1.51 USD0.79-19.55573.3KOn
3 Jul 20261.20 USD-1.6%1.00 USD1.52 USD1.00-9.33501.0KOn
26 Jun 20261.22 USD11.9%0.99 USD1.52 USD1.21-8.80815.7KOn
19 Jun 20261.09 USD-17.4%0.99 USD1.52 USD1.37-23.25714.3KOn
12 Jun 20261.32 USD-15.9%0.99 USD1.53 USD1.55-5.85653.1KOn
5 Jun 20261.57 USD27.6%0.99 USD1.53 USD1.6512.993.8MOn
29 May 20261.23 USD-18.0%0.98 USD1.53 USD1.44-16.322.0MOff
22 May 20261.50 USD48.5%0.98 USD1.54 USD1.163.021.9MOff
15 May 20261.01 USD21.6%0.97 USD1.54 USD1.04-31.261.1MOff
8 May 20260.83 USD3.2%0.98 USD1.55 USD0.91-45.46333.9KOff
1 May 20260.80 USD-1.8%1.00 USD1.56 USD1.04-46.21149.7KOff
24 Apr 20260.82 USD-1.9%1.01 USD1.57 USD1.16-46.36348.3KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.